|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,450.00 GBX | -1.66% |
|
+1.10% | -0.17% |
| Jul. 11 | FDA May Fast Track Drug Reviews for Lower US Prices | MT |
| Jul. 11 | FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -1.66% | +1.10% | -0.17% | -14.76% | +22.87% | 219B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
